Zumutor Biologics raises $7.3M Pre-Series B (India, Jun 2026)

Zumutor biologics secures 7 3 million in pre series b funding - Indiatimes

Zumutor Biologics is a biotech startup focused on developing immuno-oncology therapies that harness the body's innate immune system to fight cancer. The company is advancing its clinical trials for its lead drug candidate ZM008, which is designed to enhance the immune system’s ability to target and destroy cancer cells. This funding round will support ongoing and future clinical trials, including Phase 1 and Phase 2 studies.

Zumutor biologics secures 7 3 million in pre series b funding  Indiatimes